CD144 (VE-cadherin) Monoclonal Antibody (16B1), eBioscience and 2 more items

Life Technologies Corporation was awarded contract A207_PO-0406985-V3 by the University of Virginia on September 26, 2026, with a cumulative value of $296. The contract encompasses the delivery of specialized laboratory and research reagents to support cellular and molecular biology applications. The three line items include 204 units of CD144 (VE-cadherin) Monoclonal Antibody (16B1) from eBioscience, 65 units of Dulbecco's Modified Eagle Medium (DMEM) with high glucose and pyruvate in 500 milliliter volumes, and 26 units of Trypan Blue Solution at 0.4 percent concentration.

These reagents represent consumable laboratory materials commonly utilized in cell culture, viability assays, and endothelial cell research applications. All line items are priced at $1 per unit and will be delivered to the buyer. The contract award was executed in Virginia; however, specific information regarding performance location, contract period of performance details, and annual value figures are not available in the documentation provided.